Vitacon Health: Services

Expertise

At Vitacon we specialize in performing detailed analyses designed to answer the question: what will
the cash flows from a particular biopharmaceutical asset look like over time, and why? Because so
much rests on this calculation, we are determined to help you analyze this critical piece of
information from several different angles. Vitacon is pleased to offer its research services in the
following areas: market sizing, product revenue forecasting, strategic landscape analysis,
and deal term analysis.

Market Sizing: How large is the market for a given disease? What are the current and
emerging therapies, what are physician preferences, and how will this affect future prescribing
behavior? What is the epidemiological prevalence, and how large is the addressable population?
What market growth rates should be used?

Forecasting: What is the expected sales/patient trajectory for a particular drug product? Does
one expect rapid or slow uptake post-launch? What is the expected revenue erosion due to generics
and biosimilars? What are the chances of competitors achieving launch and reducing share?

Landscape Analysis: Which mechanisms/modalities are experiencing greatest cost
containment by payers? What impact will legislative developments have on generics intrusion? What
are pharmaceutical productivity trends and how will these affect launch of new products?

Deal Term Analysis: What does the licensing agreement portend for future royalty streams?
What is the likelihood of triggering higher royalty payments in a tiered scheme? Who are the parties to
licensing, and what other obligations are there for a particular asset?

About us: Our lead principal has over ten years of experience in the pharmaceutical and biotech
industries in the field of strategic marketing and corporate development. Full bio to be released in the
near future.

Please contact us at bizdev@vitaconsult.net to open a dialogue with us.

Vitacon Health